Evidence map›Paper›PMID 35087228›Full record

ArticleNature microbiology2022

Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity.

Robert H Mills, Parambir S Dulai, Yoshiki Vázquez-Baeza, Consuelo Sauceda, Noëmie Daniel, Romana R Gerner, Lakshmi E Batachari, Mario Malfavon, Qiyun Zhu, Kelly Weldon and 13 more

Open access · greenAbstract read
In one paragraph

Article in Nature microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 221 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
221citing papers in PubMed, 3 pooled it
29.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

221 citing papers in PubMed, 3 syntheses or guidelines pooled it, 368 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Gut microbes · 2026
    Article
  8. Gut microbes · 2026
    Article
  9. Article
  10. High-throughput analyses ofGut microbes · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. From triggers to interfaces: polymer-stabilized nano-co-crystals for robust mesalazine delivery in UC.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

161 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 2 countries.

Robert H Mills *Department of Pharmacology, University of California, San Diego, CA, USA.
Parambir S Dulai *Division of Gastroenterology, University of California, San Diego, CA, USA.
Yoshiki Vázquez-BaezaDepartment of Pediatrics, University of California, San Diego, CA, USA.ORCID http://orcid.org/0000-0001-6014-2009
Consuelo SaucedaDepartment of Pharmacology, University of California, San Diego, CA, USA.ORCID http://orcid.org/0000-0002-1487-6631
Noëmie DanielINSERM U1016, team Mucosal microbiota in chronic inflammatory diseases, CNRS UMR 8104, Université de Paris, Paris, France.
Romana R GernerDepartment of Pediatrics, University of California, San Diego, CA, USA.ORCID http://orcid.org/0000-0003-2377-6509
Lakshmi E BatachariDepartment of Pathology, University of California, San Diego, CA, USA.ORCID http://orcid.org/0000-0003-0553-1858
Mario MalfavonDepartment of Pharmacology, University of California, San Diego, CA, USA.
Qiyun ZhuDepartment of Pediatrics, University of California, San Diego, CA, USA.
Kelly WeldonCenter for Microbiome Innovation, University of California, San Diego, CA, USA.ORCID http://orcid.org/0000-0003-1064-8153
Greg HumphreyDepartment of Pediatrics, University of California, San Diego, CA, USA.
Marvic Carrillo-TerrazasDepartment of Pharmacology, University of California, San Diego, CA, USA.
Lindsay DeRight GoldasichDepartment of Pediatrics, University of California, San Diego, CA, USA.
MacKenzie BryantDepartment of Pediatrics, University of California, San Diego, CA, USA.
Manuela RaffatelluCenter for Microbiome Innovation, University of California, San Diego, CA, USA.ORCID http://orcid.org/0000-0001-6487-4215
Robert A QuinnDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA.
Andrew T GewirtzCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.
Benoit ChassaingINSERM U1016, team Mucosal microbiota in chronic inflammatory diseases, CNRS UMR 8104, Université de Paris, Paris, France.
Hiutung ChuDepartment of Pathology, University of California, San Diego, CA, USA.
William J SandbornDivision of Gastroenterology, University of California, San Diego, CA, USA.
Pieter C DorresteinSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA, USA.ORCID http://orcid.org/0000-0002-3003-1030
Rob KnightDepartment of Pediatrics, University of California, San Diego, CA, USA. robknight@ucsd.edu.
David J GonzalezDepartment of Pharmacology, University of California, San Diego, CA, USA. djgonzalez@ucsd.edu.ORCID http://orcid.org/0000-0003-1423-5970
University of California San Diego · USCentre National de la Recherche Scientifique · FRGeorgia State University · USMichigan State University · US

Funding

San Diego Digestive Diseases Research CenterP30DK120515 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Bernd G. Schnabl · 2019 to 2026
$10.8M
U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
Training Grant in GastroenterologyT32DK007202 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 1985 to 2022
$7.7M
NIDDK NIH HHS P30 DK120515NIDDK NIH HHS T32 DK007202NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

Ulcerative colitis (UC) is driven by disruptions in host-microbiota homoeostasis, but current treatments exclusively target host inflammatory pathways. To understand how host-microbiota interactions become disrupted in UC, we collected and analysed six faecal- or serum-based omic datasets (metaproteomic, metabolomic, metagenomic, metapeptidomic and amplicon sequencing profiles of faecal samples and proteomic profiles of serum samples) from 40 UC patients at a single inflammatory bowel disease centre, as well as various clinical, endoscopic and histologic measures of disease activity. A validation cohort of 210 samples (73 UC, 117 Crohn's disease, 20 healthy controls) was collected and analysed separately and independently. Data integration across both cohorts showed that a subset of the clinically active UC patients had an overabundance of proteases that originated from the bacterium Bacteroides vulgatus. To test whether B. vulgatus proteases contribute to UC disease activity, we first profiled B. vulgatus proteases found in patients and bacterial cultures. Use of a broad-spectrum protease inhibitor improved B. vulgatus-induced barrier dysfunction in vitro, and prevented colitis in B. vulgatus monocolonized, IL10-deficient mice. Furthermore, transplantation of faeces from UC patients with a high abundance of B. vulgatus proteases into germfree mice induced colitis dependent on protease activity. These results, stemming from a multi-omics approach, improve understanding of functional microbiota alterations that drive UC and provide a resource for identifying other pathways that could be inhibited as a strategy to treat this disease.

Indexed as

AdultAnimalsBacterial ProteinsBacteroidesCohort StudiesColitis, UlcerativeFecesFemaleGastrointestinal MicrobiomeHumansLongitudinal StudiesMaleMetagenomeMetagenomicsMiceMiddle AgedBacterial ProteinsPeptide Hydrolases

Identifiers

PMID35087228
PMCPMC8852248
OpenAlexW4213182271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.